These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26055242)

  • 1. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program.
    Bhola R; Kinsella E; Giffin N; Lipscombe S; Ahmed F; Weatherall M; Goadsby PJ
    J Headache Pain; 2015; 16():535. PubMed ID: 26055242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
    Lipton RB; Dodick DW; Silberstein SD; Saper JR; Aurora SK; Pearlman SH; Fischell RE; Ruppel PL; Goadsby PJ
    Lancet Neurol; 2010 Apr; 9(4):373-80. PubMed ID: 20206581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
    Starling AJ; Tepper SJ; Marmura MJ; Shamim EA; Robbins MS; Hindiyeh N; Charles AC; Goadsby PJ; Lipton RB; Silberstein SD; Gelfand AA; Chiacchierini RP; Dodick DW
    Cephalalgia; 2018 May; 38(6):1038-1048. PubMed ID: 29504483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.
    Irwin SL; Qubty W; Allen IE; Patniyot I; Goadsby PJ; Gelfand AA
    Headache; 2018 May; 58(5):724-731. PubMed ID: 29528485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine-associated symptoms: A post hoc analysis.
    Cohen F; Friedman BW
    Headache; 2021 Sep; 61(8):1227-1233. PubMed ID: 34363617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
    Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB
    Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis.
    Lloyd JO; Hill B; Murphy M; Al-Kaisy A; Andreou AP; Lambru G
    J Headache Pain; 2022 Jun; 23(1):63. PubMed ID: 35668368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trial.
    Engel ER; Cheng J
    Neurol Sci; 2020 Mar; 41(3):537-542. PubMed ID: 31833000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
    Silberstein SD; Stauffer VL; Day KA; Lipsius S; Wilson MC
    J Headache Pain; 2019 Jun; 20(1):75. PubMed ID: 31253091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
    Dodick DW; Tepper SJ; Friedman DI; Gelfand AA; Kellerman DJ; Schmidt PC
    Headache; 2018 Jul; 58(7):986-992. PubMed ID: 29782049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased migraine-free intervals with multifocal repetitive transcranial magnetic stimulation.
    Leahu P; Bange M; Ciolac D; Scheiter S; Matei A; Gonzalez-Escamilla G; Chirumamilla VC; Groppa SA; Muthuraman M; Groppa S
    Brain Stimul; 2021; 14(6):1544-1552. PubMed ID: 34673259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled trial of telcagepant for the acute treatment of migraine.
    Connor KM; Shapiro RE; Diener HC; Lucas S; Kost J; Fan X; Fei K; Assaid C; Lines C; Ho TW
    Neurology; 2009 Sep; 73(12):970-7. PubMed ID: 19770473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical Mechanisms of Single-Pulse Transcranial Magnetic Stimulation in Migraine.
    Lloyd JO; Chisholm KI; Oehle B; Jones MG; Okine BN; Al-Kaisy A; Lambru G; McMahon SB; Andreou AP
    Neurotherapeutics; 2020 Oct; 17(4):1973-1987. PubMed ID: 32632772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study.
    Alpuente A; Torre-Sune A; Caronna E; Gine-Cipres E; Torres-Ferrús M; Pozo-Rosich P
    Cephalalgia; 2023 Aug; 43(8):3331024231177636. PubMed ID: 37555331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic simulation in the treatment of migraine.
    Lipton RB; Pearlman SH
    Neurotherapeutics; 2010 Apr; 7(2):204-12. PubMed ID: 20430320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
    Ament M; Day K; Stauffer VL; Skljarevski V; Rettiganti M; Pearlman E; Aurora SK
    J Headache Pain; 2021 Feb; 22(1):6. PubMed ID: 33549036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial Magnetic Stimulation: Basic Principles and Clinical Applications in Migraine.
    Barker AT; Shields K
    Headache; 2017 Mar; 57(3):517-524. PubMed ID: 28028801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
    Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA
    Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.